Skip to content
About Us
History
Leadership
Scientific Advisory Board
Collaboration and Partnership
Locations
Our Science
Small Molecules
ADC Platform
Pipeline
Small Molecules
Kinases
Encorafenib (BRAF)
Entrectinib (TRK, ROS)
Onvansertib (PLK1)
NMS-153 (MPS1)
NMS-812 (PERK/ GCN2)
Early Pipeline Projects
NAD+ Binding Family: PARP
NMS-293 (PARP1)
Atamparib (PARP7)
ADC Platform
Peptide Drug Conjugate (PDC)
Antibody Drug Conjugate (ADC)
Platform of Payload- Linkers
News/Events & Publications
News
Events
Publications
Careers
Contact Us
About Us
History
Leadership
Scientific Advisory Board
Collaboration and Partnership
Locations
Our Science
Small Molecules
ADC Platform
Pipeline
Small Molecules
Kinases
Encorafenib (BRAF)
Entrectinib (TRK, ROS)
Onvansertib (PLK1)
NMS-153 (MPS1)
NMS-812 (PERK/ GCN2)
Early Pipeline Projects
NAD+ Binding Family: PARP
NMS-293 (PARP1)
Atamparib (PARP7)
ADC Platform
Peptide Drug Conjugate (PDC)
Antibody Drug Conjugate (ADC)
Platform of Payload- Linkers
News/Events & Publications
News
Events
Publications
Careers
Contact Us
Search
International School of Process chemistry
Home
/
News/Events & Publications
/ International School of Process chemistry
May 12-15
Gargnano, Italy
International School of Process chemistry
Terapie personalizzate nelle neoplasie mieloidi
Glioma in 2019: Standard of care of IDHwt glioblastoma and IDHmt lower grade glioma Martin Van Den Bent
Share this page
Facebook
Twitter
LinkedIn
Email
svg.e-font-icon-svg {display:none!important} .elementor-button-icon {display:none!important} .show-more, .show-more2 {display:none!important}